184.71
price up icon0.49%   0.90
 
loading

Beigene Ltd Adr Stock (BGNE) Latest News

pulisher
Feb 25, 2025

Beigene's global head of R&D sells $1.29m in shares - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.

Feb 25, 2025
pulisher
Feb 21, 2025

BeiGene stock soars to 52-week high of $258.66 amid robust growth - Investing.com India

Feb 21, 2025
pulisher
Feb 20, 2025

BeiGene's president sells $12.5 million in company shares - Investing.com

Feb 20, 2025
pulisher
Feb 08, 2025

Beigene's Wang Xiaodong sells $9.4 million in shares - Investing.com India

Feb 08, 2025
pulisher
Feb 06, 2025

Beigene's Wang Xiaodong sells $9.4 million in shares By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Jan 15, 2025

CCBI Adds BEIGENE's TP to $179 for Better Fundamentals This Yr - AASTOCKS.com

Jan 15, 2025
pulisher
Jan 13, 2025

BEIGENE (06160.HK) Climbs 6% in Early Session, Expects to Achieve Positive Operating Income This Yr - AASTOCKS.com

Jan 13, 2025
pulisher
Jan 08, 2025

Beigene director Wang Xiaodong sells $7.37 million in shares - Investing.com

Jan 08, 2025
pulisher
Jan 05, 2025

HSBC Global Research Prefers BeiGene/ SINO BIOPHARM/ HYGEIA HEALTH Given Higher Visibility in CN Pharma & Medical Device Subsectors - AASTOCKS.com

Jan 05, 2025
pulisher
Dec 31, 2024

(NASDAQ:BGNE) Stock Quotes, Forecast and News Summary - Benzinga

Dec 31, 2024
pulisher
Dec 27, 2024

FDA approves BeiGene's TEVIMBRA for advanced gastric cancer treatment - Investing.com

Dec 27, 2024
pulisher
Dec 24, 2024

With 45% institutional ownership, BeiGene, Ltd. (NASDAQ:BGNE) is a favorite amongst the big guns - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 23, 2024
pulisher
Dec 17, 2024

BeiGene shares reiterate Buy rating on robust oncology pipeline - Investing.com India

Dec 17, 2024
pulisher
Dec 10, 2024

Beigene directors sell shares worth $194.2 million - Investing.com

Dec 10, 2024
pulisher
Dec 10, 2024

Beigene president Wu Xiaobin reports $120,894 sale of economic interest By Investing.com - Investing.com South Africa

Dec 10, 2024
pulisher
Dec 10, 2024

Beigene president Wu Xiaobin reports $120,894 sale of economic interest - Investing.com

Dec 10, 2024
pulisher
Dec 04, 2024

Beigene sees $3.57 billion stock sale by Hillhouse Investment By Investing.com - Investing.com South Africa

Dec 04, 2024
pulisher
Dec 04, 2024

Beigene sees $274 million stock sale by Hillhouse Investment By Investing.com - Investing.com

Dec 04, 2024
pulisher
Dec 03, 2024

AGFA Gevaert NV (AGFB.BR) Stock Price, News & Analyst Forecast - eToro

Dec 03, 2024
pulisher
Dec 03, 2024

Morgan Stanley increases BeiGene stock target on drug prospects - Investing.com

Dec 03, 2024
pulisher
Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024
pulisher
Nov 29, 2024

Beigene's Wang Xiaodong sells shares worth $9.19 million - Investing.com

Nov 29, 2024
pulisher
Nov 29, 2024

BeiGene stock outlook positive as Bernstein lifts price target, keeps Market Perform - Investing.com

Nov 29, 2024
pulisher
Nov 20, 2024

China ADRs have increased to the largest share since late 2021 – GS - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

BeiGene settles patent litigation, extends BRUKINSA exclusivity - Investing.com

Nov 19, 2024
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 14, 2024

BeiGene announces name change to BeOne Medicines Ltd. - Investing.com

Nov 14, 2024
pulisher
Nov 13, 2024

BeiGene shares lift on raised price target to $260 from $254 - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

UBS Raises BeiGene (BGNE.US) TP to US$289.7 as 3Q Results Beat - AASTOCKS.com

Nov 12, 2024
pulisher
Nov 12, 2024

BeiGene shares fall despite better-than-expected Q3 results - Investing.com

Nov 12, 2024
pulisher
Oct 28, 2024

BeiGene announces passing of board member Donald Glazer - Investing.com

Oct 28, 2024
pulisher
Oct 25, 2024

BEIGENE Senior Staff Reportedly Investigated, but Not Related to Firm Operations - AASTOCKS.com

Oct 25, 2024
$357.50
price down icon 0.20%
$33.69
price down icon 0.33%
$22.96
price up icon 2.04%
$74.40
price up icon 0.53%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):